Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jason A Keyes Insider Profile
4 Followers
Jason A Keyes, SVP, Chief Financial Officer at Orexigen, holds 136.63K shares in Equillium (Ticker: EQ), holds 40.00K shares in Carisma Therapeutics (Ticker: CARM), holds 21.83K shares in Orexigen (Ticker: OREXQ).
Jason A Keyes Orexigen (OREXQ)SVP, Chief Financial Officer
Orexigen (OREXQ)
SVP, Chief Financial Officer
Not Ranked
Jason A Keyes has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Jason A Keyes
Jason A Keyes's Trading History
Orexigen
Jun 02, 2017
―
Uninformative Buy
863.35
$109.16
Equillium
Jan 03, 2024
CFO
Uninformative Buy
13.51K
$199.48K
Carisma Therapeutics
Jun 24, 2022
Director
Uninformative Buy
―
$65.20K
List of latest transactions for each holding click on a transaction to see Jason A Keyes's performance on stock
You May Also Like
Jason A Keyes insider profile FAQ
What is the percentage of profitable transactions made by Jason A Keyes?
The percentage of profitable transactions made by Jason A Keyes is ―.
What is the average return per transaction made by Jason A Keyes?
The average return per transaction made by Jason A Keyes is ―.
What stocks does Jason A Keyes hold?
Jason A Keyes holds: OREXQ, EQ, CARM stocks.
What was Jason A Keyes’s latest transaction?
Jason A Keyes latest transaction was an Uninformative Buy of $13.51K.
What was Jason A Keyes's most profitable transaction?
Jason A Keyes’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Jason A Keyes's role in Orexigen?
Jason A Keyes's role in Orexigen is SVP, Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.